KPTI   $7.63  -1.29% Market Closed After Close 7.7 0.92%

Karyopharm Therapeutics Inc.
Total Cash 152.12M
totalCashPerShare 1.22
EBITDA -130.61M
Total Debt 269.13M
quickRatio 3.31
currentRatio 3.619
Total Revenue 145.67M
debtToEquity
Revenue/Share 1.251
ROA -0.31982002
ROE
grossProfits
freeCashflow -79.55M
operatingCashflow -130.34M
earningsGrowth
revenueGrowth 0.139
grossMargins 0.89185995
ebitdaMargins -0.89666003
operatingMargins -0.65722
profitMargins -0.61724997
enterpriseValue 233.34M
forwardPE -1.1745833
floatShares 113.28M
sharesOutstanding 124.68M
sharesShort 17.61M
sharesShortPriorMonth 17.93M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.56%
Short Ratio help_outline 21.23%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue -1.185
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -89.91M
trailingEps -1.05%
forwardEps -0.72%
enterpriseToEbitda -1.79
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.24 4Q 2024
institutionsCount 135
lastUpdated Nov. 6, 2024, 5:24 p.m.